1. 21CFR320.1, 2014. Title 21: Food and Drugs: Part 320—Bioavailability and Bioequivalence Requirements, Subpart A—General Provisions. Available at http://ecfr.gpoaccess.gov/cgi/t/text/text-idx?c=ecfr&sid=a2c8242fba4332eaa1b90947931245a3&rgn=div5&view=text&node=21:5.0.1.1.7&idno=21#21:5.0.1.1.7.1.1.1H (accessed 30.3.14).
2. 21CFR320.24, 2014. Title 21: Food and Drugs: PART 320—Bioavailability and Bioequivalence Requirements, Subpart B—Procedures for Determining the Bioavailability or Bioequivalence of Drug Products. Available at http://www.ecfr.gov/cgi-bin/text-idx?SID=301bbb87cfab41036bc82f497f1aa9aa&node=pt21.5.320&rgn=div5#se21.5.320_124 (accessed 30.3.2014).
3. Chapter 58: Antiviral agents (Nonretroviral);Acosta,2011
4. The hairless guinea-pig as a model for treatment of cumulative irritation in humans;Andersen;Skin. Res. Technol.,2006
5. The yield stress – a review or ‘pi alpha nu tau alpha rho epsilon iota' – everything flows?;Barnes;J Non-Newton. Fluid. Mech.,1999